Posted in | News

Labcyte Awarded U.S. Patent for Transferring Liquids Within Sealed Containers

Labcyte Inc. announces the issuance of U.S. Patent 7,405,072, which uses the unique advantages of moving liquids with sound to transfer fluids within a sealed container, free from any physical contact. This process can be applied to the testing of pathogens and other dangerous fluids.

“A pathogen-containing liquid can be introduced into a vessel and permanently sealed. We can then use sound energy to move that liquid with high precision and accuracy within the vessel without ever physically touching the liquid. For example, we can transfer a droplet of a liquid, including blood, from a sample pool within the sealed vessel onto a receiving surface that contains specific test chemistry,” said Chief Technical Officer, Richard Ellson. “Sound waves enter the container, but the pathogens cannot leave. Since acoustic transfer is completely ‘touchless’ and eliminates pipette transfers, there is no contamination of pipette tips, labware, or other samples. Wash solutions are not necessary.”

Acoustic droplet ejection allows volume transfers of a few nanoliters or less. This technology enables miniaturization of biological assays. Transferring liquids within a sealed container minimizes exposure risk for technicians who handle the samples.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.